Home
Conditions
Multiple Myeloma

Clinical trial condition

Multiple Myeloma

Explore clinical trials studying Multiple Myeloma. Study availability and eligibility vary by location and protocol.

2,608 public trials 494 recruiting studies

Refine in advanced search Browse all conditions

Multiple Myeloma trial results

Recruiting

A Dose Escalating Study of CD19/CD22/BCMA CAR-T Therapy in Relapsed/ Refractory Multiple Myeloma

NCT06732232

Conditions: Blood Protein Disorders, Cardiovascular Diseases, Disease Attributes, +18 more
Locations: China, Shanghai Mengchao Cancer Hospital Shanghai, China

View Trial Details

Recruiting

a Study of CT0596 in Relapsed/Refractory Multiple Myeloma and Relapsed/Refractory Plasma Cell Leukemia

NCT06718270

Conditions: Blood Protein Disorders, Cardiovascular Diseases, Disease Attributes, +20 more
Locations: Shanghai Changzheng Hospital Shanghai, Shanghai Municipality, China

View Trial Details

Recruiting

Real World Insights During Treatment for Relapsed/Refractory Multiple Myeloma with Isatuximab

NCT05053607

Conditions: Blood Protein Disorders, Cardiovascular Diseases, Hematologic Diseases, +13 more
Locations: The University of Texas MD Anderson Cancer Center Houston, Texas, United States

University of Washington Seattle, Washington, United States

View Trial Details

Recruiting

The Unmet Needs of Cancer Survivors in Ausl IRCCS Reggio Emilia

NCT06236373

Conditions: Blood Protein Disorders, Breast Cancer, Breast Diseases, +46 more
Locations: Casa della Salute ex Spallanzani Reggio Emilia, Italy

View Trial Details

Recruiting

Prospective Evaluation of the Prognostic Impact of Measurable Residual Disease (MRD) Within a Phase III Study Comparing a Fixed Duration Therapy Versus Continuous Therapy With Daratumumab, Lenalidomide, and Dexamethasone for Relapsed Multiple Myeloma Requiring a First Salvage Treatment.

NCT05203003

Conditions: Blood Protein Disorders, Cardiovascular Diseases, Hematologic Diseases, +16 more
Locations: Department of Hematology, Hospital Saint Antoine Paris, France

View Trial Details

Recruiting

A Clinical Study of TQB2029 for Injection in Subjects With Multiple Myeloma

NCT06700395

Conditions: Blood Protein Disorders, Cardiovascular Diseases, Hematologic Diseases, +12 more
Locations: Zhongshan Hospital of Fudan University Shanghai, Shanghai Municipality, China

West China hospital, Sichuan university Chengdu, Sichuan, China

View Trial Details

Recruiting

Examination of Vertebroplasty in Addition to Regular Treatment of Patients With Multiple Myeloma.

NCT04533217

Conditions: Back Injuries, Blood Protein Disorders, Cardiovascular Diseases, +18 more
Locations: Center for Spine Surgery and Research Middelfart, Region Syddanmark, Denmark

View Trial Details

Recruiting

Bortezomib-bendamustine-melphalan vs Melphalan for Multiple Myeloma

NCT06245629

Conditions: Blood Protein Disorders, Cardiovascular Diseases, Hematologic Diseases, +13 more
Locations: Akademiska sjukhuset Uppsala, Sweden

View Trial Details

Recruiting

Risk Stratification and MRD-driven Maintenance for MM After ASCT

NCT06697483

Conditions: Blood Protein Disorders, Cardiovascular Diseases, Hematologic Diseases, +16 more
Locations: Fuxing Hospital Beijing, Beijing Municipality, China

Peking Union Medical College Hospital Beijing, Beijing Municipality, China

Peking University People's Hospital Beijing, Beijing Municipality, China

The First Affiliated Hospital of Harbin Medical University Harbin, Heilongjiang, China

View Trial Details

Recruiting

Olanzapine 2.5 vs 5 mg in Quadruplet Nausea/Vomiting Prophylaxis Before High-Dose Melphalan

NCT06588413

Conditions: Autologous Stem Cell Transplantation, Blood Protein Disorders, Cardiovascular Diseases, +17 more
Locations: Wellstar MCG Augusta, Georgia, United States

View Trial Details

Multiple Myeloma

Multiple Myeloma trial results

Related conditions